MicroRNA-17 inhibits tumor growth by stimulating T-cell mediated host immune response

BACKGROUND: Melanoma is one of the fastest-rising types of cancer in North American. Accumulating evidence suggests that anti-tumor immune tolerance plays a critical role in tumor development. METHODS: B16 melanoma cells were injected into wild type and miR-17 overexpressing transgenic mice. Tumor g...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Haoran, Gupta, Shaan, Du, William W., Yang, Burton B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278315/
https://www.ncbi.nlm.nih.gov/pubmed/25594054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278315/
https://www.ncbi.nlm.nih.gov/pubmed/25594054

Ejemplares similares